Physician profile
Kevin A Nadel
NPI 1407822935
$3,473.79
in general payments reported to CMS, 2019-2025
10 companies · $291 in 2025
The $291 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,271 · 2020: $807 · 2021: $461 · 2022: $218 · 2023: $157 · 2024: $269 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Micromed INC | $1,868.56 | 2019-2020 | |
| Smith+Nephew, INC. | $764.95 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Q-Fix, Healicoil |
| Team_makena_llc | $463.80 | 2019-2021 | |
| Stryker Corporation | $173.15 | 2022 | |
| Catalyst Orthoscience | $61.68 | 2025 | |
| Saxum Surgical, INC. | $44.42 | 2022 | |
| Moximed, INC | $35.45 | 2025 | Misha Knee System, Small, Left |
| Horizon Therapeutics Plc | $26.82 | 2020-2021 | |
| Depuy Synthes Sales INC. | $19.32 | 2023 | Monovisc |
| Linvatec Corporation | $15.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Nadel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.